⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL17309998 | 0.95 | CYP2C9 (0.44) | — | |
| SCHEMBL34468141 | 0.95 | CYP2C9 (0.44) | — | |
| Water SCHEMBL28967112 | 0.95 | — | — | |
| SCHEMBL1269845 | 0.95 | CYP2C9 (0.44) | — | |
| SCHEMBL1269342 | 0.95 | CYP2C9 (0.44) | — | |
| Ammonia Solution, Strong SCHEMBL3799540 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL1937438 | 0.95 | — | — | |
| SCHEMBL6585508 | 0.91 | — | — | |
| SCHEMBL7075565 | 0.91 | TDP1 (0.41) | — | |
| Water SCHEMBL28967125 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 35960 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114981316-B | Process for producing branched polydienes | 公共型股份公司希布尔控股 | 2024-07-30 | — | — | CN | claimed |
| WO-2024151519-A2 | PPARG MODULATORS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATIN, INCORPORATED (US) | 2024-07-18 | — | — | WO | claimed |
| EP-4399206-A1 | PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES | Redona Therapeutics, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| EP-4399212-A1 | SUBSTITUTED 2,3-DIHYDRO[1,3]THIAZOLO[4,5-B]PYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2024-07-17 | — | — | EP | claimed |
| EP-4392412-A1 | ABAD INHIBITOR COMPOUNDS | University Court of The University of St Andrews (GB) | 2024-07-03 | — | — | EP | claimed |
| CN-118265707-A | Pesticidally active pyridazinone compounds | 先正达农作物保护股份公司 | 2024-06-28 | — | — | CN | claimed |
| US-20240207268-A1 | PYRAZOLYLPYRIMIDINES FOR TREATING MALIGNANT SOLID TUMOR | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-06-27 | — | — | US | claimed |
| WO-2024138201-A2 | SELECTIVE BET INHIBITORS AND USES THEREOF | Tay Therapeutics Limited (GB) | 2024-06-27 | — | — | WO | claimed |
| US-20240207253-A1 | Inhibitors of CDR1 for Reversal of Azole Drug Resistance in Fungal Infections | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2024-06-27 | — | — | US | claimed |
| CN-118239883-A | Preparation method of lysine-specific demethylase 1 (LSD 1) inhibitor | 江苏联环药业股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-4120947-A | Xanthine compounds and method of treating bronchospastic and allergic diseases | COOPER LABORATORIES, INC. (US) | 1978-10-17 | — | — | US | claimed |
| US-4089959-A | Long-acting xanthine bronchodilators and antiallergy agents | COOPER LABORATORIES, INC. (US) | 1978-05-16 | — | — | US | claimed |
| US-4077977-A | Ethenoanthracenes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-03-07 | — | — | US | claimed |
| US-4016167-A | ANALGESICS, NARCOTIC ANTAGONISTS | BRISTOL-MYERS COMPANY (US) | 1977-04-05 | — | — | US | claimed |
| US-4001248-A | ANALGETIC AGONIST AND ANTAGONIST | ELI LILLY AND COMPANY (US) | 1977-01-04 | — | — | US | claimed |
| US-3991199-A | ANALGESICS AND SEDATIVES | ENDO LABORATORIES, INC. (US) | 1976-11-09 | — | — | US | claimed |
| US-RE29003-E | ANTIBIOTICS | HOFFMANN-LA ROCHE INC. (US) | 1976-10-12 | — | — | US | claimed |
| US-3957758-A | ANTIBIOTICS | HOFFMANN-LA ROCHE INC. (US) | 1976-05-18 | — | — | US | claimed |
| US-3956323-A | ANTIBIOTICS | HOFFMANN-LA ROCHE INC. (US) | 1976-05-11 | — | — | US | claimed |
| US-3936463-A | ANALGESIC | BAYER AKTIENGESELLSCHAFT (DT) | 1976-02-03 | — | — | US | claimed |